系统免疫炎症指数与接受新辅助化疗胰腺导管腺癌患者预后的关系
赵阳， 程静 - 中国癌症防治杂志, 2020 - zgazfz.com
… survival of PDAC patients. Conclusion SII跃885 suggests poor prognosis in patients with …
after neoadjuvant chemotherapy. [Key words]Pancreatic ductal adenocarcinoma;Systemic …
after neoadjuvant chemotherapy. [Key words]Pancreatic ductal adenocarcinoma;Systemic …
[HTML][HTML] 胰腺癌新辅助治疗和转化治疗的现状与展望
李珂珂， 孔盼盼， 晏冬， 王喜艳 - 生物医学转化, 2020 - swyxzh.ijournals.cn
… of pancreatic ductal adenocarcinoma-A systematic review and … term survival after curative
resection for pancreatic ductal … This article systematically sorts out the clinical application of …
resection for pancreatic ductal … This article systematically sorts out the clinical application of …
腹腔镜与开腹胰体尾切除术对胰腺导管腺癌的治疗经验
A Zhang, Y Wang, C Hu, Y Shen, S Zheng - Journal of Zhejiang University …, 2017 - Springer
… performed for pancreatic ductal adenocarcinoma during a 4-year … underwent LDP for pancreatic
ductal adenocarcinoma, in … survival after pancreatectomy for pancreatic adenocarcinoma…
ductal adenocarcinoma, in … survival after pancreatectomy for pancreatic adenocarcinoma…
[PDF][PDF] 基于术前FAR 和SII 的预后模型与TNM 分期系统在评估胰腺癌根治术患者预后中的比较
刘旭东， 赵斌， 杜鹏， 张国强， 郑强， 赖佳敏， 程志斌 - 肿瘤防治研究, 2023 - zlfzyj.com
… /albumin ratio (FAR) and systemic immune inflammation index (SII) on the postoperative
prognosis of patients with pancreatic ductal adenocarcinoma. Methods An ROC curve was used …
prognosis of patients with pancreatic ductal adenocarcinoma. Methods An ROC curve was used …
炎症反应相关评分系统在判断胰腺癌预后中的意义
刘海亮， 刘荣 - 解放军医学院学报, 2016 - xuebao.301hospital.com.cn
… scoring systems that related to pancreatic adenocarcinoma. … is associated with survival
after surgery for colorectal cancer[J]… curative surgery for pancreatic ductal adenocarcinoma[J]. …
after surgery for colorectal cancer[J]… curative surgery for pancreatic ductal adenocarcinoma[J]. …
[HTML][HTML] 一般临床特征与血液学参数在胰腺导管腺癌根治性切除术患者中的预后价值研究
莲丽曾， 双双李， 鹏飞岳， 成易 - Journal of Sichuan University …, 2024 - ncbi.nlm.nih.gov
… To explore the relationship between baseline clinical characteristics and hematological
parameters of patients undergoing radical resection for pancreatic ductal adenocarcinoma (…
parameters of patients undergoing radical resection for pancreatic ductal adenocarcinoma (…
Babaodan Capsule (八宝丹胶囊) combined with Qingyi Huaji Formula (清胰化积方) in advanced pancreatic cancer—a feasibility study
L Song, S Gao, A Zhang, X Qian, L Liu - Chinese journal of integrative …, 2017 - Springer
… Only 2%–4% patients survive over 5 years after treatment.(1) Systemic chemotherapy and/or …
advanced or metastatic pancreatic cancer, but the results have been unsatisfactory.(2) …
advanced or metastatic pancreatic cancer, but the results have been unsatisfactory.(2) …
全胰切除术对胰腺肿瘤的近远期疗效分析
周文涛， 韩思阳， 徐天威， 匡天涛， 戎叶飞… - 肝胆胰外科 …, 2022 - gdy.qk.wmu.edu.cn
… pathological types included pancreatic ductal adenocarcinoma (PDAC, n=… patients acquired
better long-term survival after TP (35.8 months vs 15.0 … Results of a systematic review [J]. …
better long-term survival after TP (35.8 months vs 15.0 … Results of a systematic review [J]. …
IS-S3-1 指_ G Advance in the treatment of IBD
K Matsuoka - jstage.jst.go.jp
… survival after resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma. …
EUS-RFA can be combined with systemic chemotherapy and SBRT for local management …
EUS-RFA can be combined with systemic chemotherapy and SBRT for local management …
IS-S1-1 指_ H Autoimmune hepatitis in
A Takahashi, H Ohira - jstage.jst.go.jp
… more effective systemic therapies, e)… pancreatic duct are technically difficult. We have
devised new surgical techniques, including intestinal derotation procedure and pancreatic duct …
devised new surgical techniques, including intestinal derotation procedure and pancreatic duct …